CJC-1295 with DAC is a synthetic modified peptide compound engineered for laboratory research. The molecule features a Drug Affinity Complex (DAC) modification that enhances its stability in experimental conditions. Laboratory research demonstrates specific molecular pathway interactions and distinct binding properties in controlled models. The compound is designed with a 30-amino acid sequence structure, showing selective receptor affinity in vitro studies.
The DAC modification allows for extended stability in solution compared to the non-modified variant, making it particularly suitable for prolonged laboratory studies.
Reviews
There are no reviews yet.